文献库，生知库 | 链接生命科学的每一步

日期影响因子

Resistance to the KRAS(G12D) Inhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition

对KRAS(G12D)抑制剂MRTX1133的耐药性与对BET抑制剂的敏感性增加相关

doi:10.1101/2025.05.10.653074

Principe, Daniel R; Becker, Jeffrey H; Metropulos, Anastasia E; Marinelarena, Alejandra M; Pham, Thao D; Aissa, Alexandre F; Munshi, Hidayatullah G

发表日期：2025

文献求助收藏

Regorafenib induces DNA damage and enhances PARP inhibitor efficacy in pancreatic ductal carcinoma.

瑞戈非尼可诱导DNA损伤，并增强PARP抑制剂在胰腺导管癌中的疗效

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-024-13334-y

Pham Thao D, Becker Jeffrey H, Metropulos Anastasia E, Mubin Nida, Spaulding Christina, Bentrem David J, Munshi Hidayatullah G

发表日期：2024

文献求助收藏

Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer

STK11缺失抑制脂质代谢并减弱非小细胞肺癌患者的KRAS诱导的免疫原性

期刊:Cancer Research Communications

影响因子:3.3

doi:10.1158/2767-9764.CRC-24-0153

Principe, Daniel R; Pasquinelli, Mary M; Nguyen, Ryan H; Munshi, Hidayatullah G; Hulbert, Alicia; Aissa, Alexandre F; Weinberg, Frank

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Richard Hynes, Erkki Ruoslahti, and Timothy Springer receive Lasker prize for pioneering work on integrins

Richard Hynes、Erkki Ruoslahti 和 Timothy Springer 因在整合素领域的开创性工作而荣获拉斯克奖。

期刊:Journal of Clinical Investigation

影响因子:13.6

doi:10.1172/JCI164374

Munshi, Hidayatullah G

发表日期：2022

文献求助收藏

The immune modifying effects of chemotherapy and advances in chemo-immunotherapy

化疗的免疫调节作用及化疗免疫疗法的进展

期刊:Pharmacology & Therapeutics

影响因子:12.5

doi:10.1016/j.pharmthera.2022.108111

Principe, Daniel R; Kamath, Suneel D; Korc, Murray; Munshi, Hidayatullah G

免疫/内分泌

发表日期：2022

文献求助收藏

The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial

将TGFβ和免疫检查点抑制剂联合治疗的临床前成功转化为临床试验的难度

期刊:EBioMedicine

影响因子:10.8

doi:10.1016/j.ebiom.2022.104380

Metropulos, Anastasia E; Munshi, Hidayatullah G; Principe, Daniel R

免疫/内分泌

发表日期：2022

文献求助收藏

Trials and tribulations of pancreatic cancer immunotherapy

胰腺癌免疫疗法的挑战与磨难

期刊:Cancer Letters

影响因子:10.1

doi:10.1016/j.canlet.2021.01.031

Principe, Daniel R; Korc, Murray; Kamath, Suneel D; Munshi, Hidayatullah G; Rana, Ajay

免疫/内分泌

发表日期：2021

文献求助收藏

Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies

胰腺导管腺癌的临床前模型及其在免疫治疗研究中的应用

影响因子:4.4

doi:10.3390/cancers13030440

Pham, Thao N D; Shields, Mario A; Spaulding, Christina; Principe, Daniel R; Li, Bo; Underwood, Patrick W; Trevino, Jose G; Bentrem, David J; Munshi, Hidayatullah G

免疫/内分泌

发表日期：2021

文献求助收藏

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

调节性T细胞是肺癌免疫检查点抑制治疗面临的新兴障碍

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.684098

Principe, Daniel R; Chiec, Lauren; Mohindra, Nisha A; Munshi, Hidayatullah G

细胞生物学

免疫/内分泌

发表日期：2021

文献求助收藏

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy

胰腺导管腺癌的当前治疗模式及治疗效果障碍

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.688377

Principe, Daniel R; Underwood, Patrick W; Korc, Murray; Trevino, Jose G; Munshi, Hidayatullah G; Rana, Ajay

发表日期：2021

文献求助收藏